Home Abogen Biosciences Appoints Iain McFadyen as Chief Artificial Intelligence Officer

Abogen Biosciences Appoints Iain McFadyen as Chief Artificial Intelligence Officer

Jan 04, 2026 15:10 CST Updated 15:10
Abogen

Nucleic Acid Drug Developer

Tessera Therapeutics

Gene Therapy and Gene Editing Technology Developer

LifeMine

Innovative Drug Developer

Moderna

mRNA Therapeutics Developer

On January 4, Abogen announced the appointment of Iain McFadyen as the company's Chief AI Officer and member of the Scientific Advisory Board. Iain McFadyen previously served as Chief Data Science Officer at Tessera Therapeutics and LifeMine Therapeutics, and before that, as Vice President at Moderna.